[Changes in heparinocytes during the administration of Depositon and Sequenz-Ovosiston].
During hormonal contraception with Deposiston (once a week pill) and with Sequenz-Ovosiston (14 days mestranol 0.1 mg, 7 days mestranol 0,08 mg and 2 mg chlormadinone acetate) doesn't take place a change of basophil granulocytes (heparinocytes) in blood. Under Deposiston the small elevation is somewhat lengthened, under Sequenz-Ovosiston the elevated phase is similar to those of the normal menstrual cycle. The smaller risk of thromboembolia under heparinocytopenia preventing contraceptives is discussed.
D000380:Agranulocytosis / Q000139:chemically induced; D001491:Basophils / Q000187:drug effects*; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008598:Menstruation; D008656:Mestranol / Q000009:adverse effects; D012306:Risk; D013923:Thromboembolism / Q000139:chemically induced
D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D008656:Mestranol
Veränderungen der Heparinozyten unter der Einnahme von Deposiston und Sequenz-Ovosiston